Trending Now Recombinant Human Il-27 Protein, Active Gadget [NVvsQJWt]

Trending Now Recombinant Human Il-27 Protein, Active Gadget [NVvsQJWt]

Introducing our premium Recombinant Human IL-27 Protein, a cutting-edge biotechnology product designed for researchers and scientists in the field of immunology and inflammation. This active protein is a recombinant form of interleukin-27, a crucial cytokine in modulating the immune response. With its high purity and exceptional activity, our IL-27 protein is an essential tool for various applications, including cell culture, immunological studies, and therapeutic research.

• High purity: >95% as determined by Tris-Bis PAGE
• Expressed in CHO cells with a His tag at the C-terminus
• Expresses both IL-27B and IL-27A for comprehensive research

Product Specifications and Technical Details

Our Recombinant Human IL-27 Protein is produced through a state-of-the-art expression system in CHO cells, ensuring optimal performance and stability. The protein is formulated in PBS with L-arginine and contains a C-His tag for easy detection and purification. The molecular weight of the protein is predicted to be 50.6 kDa, but due to glycosylation, it migrates to a range of 54-64 kDa on Tris-Bis PAGE. The protein is lyophilized for long-term storage and reconstituted in PBS for immediate use.

• Expression System: CHO cells
• Tag: C-His
• Expression Range: Arg21-Lys229 (IL-27B) & Phe29-Pro243 (IL-27A)

Applications and Benefits

The Recombinant Human IL-27 Protein is a versatile research tool with a wide range of applications. It is ideal for use in cell culture experiments, where it can help modulate the immune response and study the role of interleukin-27 in inflammation. Additionally, this protein is valuable for developing new therapeutic strategies targeting interleukin-27-related diseases. By using our IL-27 protein, researchers can gain valuable insights into the complex interactions between innate and adaptive immune cells.

• Applications: Cell culture, immunological studies, therapeutic research
• Benefits: Enhances research capabilities, facilitates the study of inflammation, and supports the development of new therapies
• Target Audience: Researchers in immunology, inflammation, and therapeutic drug development